OOIR: Observatory of International Research

Papers

(The H4-Index of ACS Infectious Diseases is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Recent Innovations in Bacterial Infection Detection and Treatment	136
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin	129
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies	90
Synthetic Antimicrobial Polymers in Combination Therapy: Tackling Antibiotic Resistance	82
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2	81
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses	74
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19	70
Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone	67
The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors	64
Prospecting Human Milk Oligosaccharides as a Defense Against Viral Infections	64
Exogenous Nitric Oxide Improves Antibiotic Susceptibility in Resistant Bacteria	61
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease	60
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules	60
Two Years into the COVID-19 Pandemic: Lessons Learned	59
Structure–Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae	56
Reproducible Breath Metabolite Changes in Children with SARS-CoV-2 Infection	52
Emerging Vaccine-Breakthrough SARS-CoV-2 Variants	52
Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer	51
Prioritization of Molecular Targets for Antimalarial Drug Discovery	50
A Glance at Antimicrobial Strategies to Prevent Catheter-Associated Medical Infections	48
Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens	47
Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics	45
Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities	44
From Antibacterial to Antibiofilm Targeting: An Emerging Paradigm Shift in the Development of Quaternary Ammonium Compounds (QACs)	43
An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment	42

Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?	42
Synergistic Effects of Phage–Antibiotic Combinations against Citrobacter amalonaticus	42
Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions	40
Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative	37
Heterologous Protein Expression Favors the Formation of Protein Aggregates in Persister and Viable but Nonculturable Bacteria	37
Nanomaterials: The New Antimicrobial Magic Bullet	37
HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus Infection	37
Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry	37
Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview	36
Inhibitors of L-Type Calcium Channels Show Therapeutic Potential for Treating SARS-CoV-2 Infections by Preventing Virus Entry and Spread	34
Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood Cells	34